In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeutics

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.